Intratumorally administered CV8102 in patients with advanced solid tumors: Preliminary results from completed dose escalation in study 008

dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorEigentler, T.
dc.contributor.authorHeinzerling, L.
dc.contributor.authorKrauss, J.
dc.contributor.authorWeishaupt, C.
dc.contributor.authorOchsenreither, S.
dc.contributor.authorLebbe, C.
dc.contributor.authorMohr, P.
dc.contributor.authorOliva, M.
dc.contributor.authorOberoi, H. K.
dc.contributor.authorTerheyden, P.
dc.contributor.authorPerez, J. M. Trigo
dc.contributor.authorRobert, C.
dc.contributor.authorBauernfeind, F-G.
dc.contributor.authorFluck, M.
dc.contributor.authorRichtig, E.
dc.contributor.authorSoria, A.
dc.contributor.authorKays, S-K.
dc.contributor.authorSchmitt-Bormann, B.
dc.contributor.authorFalk, M.
dc.contributor.authorGnad-Vogt, U. S.
dc.contributor.authoraffiliation[Eigentler, T.] Univ Tubingen, Dept Dermatol, Tubingen, Germany
dc.contributor.authoraffiliation[Heinzerling, L.] Univ Klin Erlangen, Dept Dermatol, Erlangen, Germany
dc.contributor.authoraffiliation[Krauss, J.] Univ Klinikum Heidelberg, Zentrum Innere Med, Krehl Klin, Dept Med Oncol, Heidelberg, Germany
dc.contributor.authoraffiliation[Weishaupt, C.] UKM Univ Hosp Muenster, Dermatol, Munster, Germany
dc.contributor.authoraffiliation[Ochsenreither, S.] Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany
dc.contributor.authoraffiliation[Lebbe, C.] Hop St Louis, AP HP, Policlin Dermatol, Paris, France
dc.contributor.authoraffiliation[Mohr, P.] Elbe Klinikum Buxtehude, Dermatol, Buxtehude, Germany
dc.contributor.authoraffiliation[Oliva, M.] Catalan Inst Oncol ICO LHospitalet, Phase Drug Dev Program 1, Barcelona, Spain
dc.contributor.authoraffiliation[Oberoi, H. K.] Vall dHebron Inst Oncol VHIO, Cellex Ctr, Med Oncol Dept, Barcelona, Spain
dc.contributor.authoraffiliation[Terheyden, P.] Univ SH Lubeck, Dermatol, Lubeck, Germany
dc.contributor.authoraffiliation[Perez, J. M. Trigo] Hosp Univ Virgen Victoria, Med Oncol Dept, Malaga, Spain
dc.contributor.authoraffiliation[Robert, C.] Inst Gustave Roussy, Dermatol Dept, Villejuif, France
dc.contributor.authoraffiliation[Bauernfeind, F-G.] Univ Klinikum Bonn, Dept Internal Med Oncol Hematol & Rheumatol 3, Bonn, Germany
dc.contributor.authoraffiliation[Fluck, M.] Fachklin Hornheide, Internist Onkol, Munster, Germany
dc.contributor.authoraffiliation[Richtig, E.] Univ Klin Dermatol & Venerol, Dermatol, Graz, Austria
dc.contributor.authoraffiliation[Soria, A.] Hosp Univ Ramon y Cajal, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Kays, S-K.] CureVac AG, Translat & Clin Sci, Frankfurt, Germany
dc.contributor.authoraffiliation[Schmitt-Bormann, B.] CureVac AG, Clin Dev, Frankfurt, Germany
dc.contributor.authoraffiliation[Falk, M.] CureVac AG, Clin Dev, Frankfurt, Germany
dc.contributor.authoraffiliation[Gnad-Vogt, U. S.] CureVac AG, Clin Dev, Frankfurt, Germany
dc.contributor.funderCureVac AG
dc.date.accessioned2025-01-07T15:21:04Z
dc.date.available2025-01-07T15:21:04Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.1394
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.1394
dc.identifier.urihttps://hdl.handle.net/10668/27062
dc.identifier.wosID700527702028
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.page.numberS853-S853
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleIntratumorally administered CV8102 in patients with advanced solid tumors: Preliminary results from completed dose escalation in study 008
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files